Slow binding inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase
- 1 May 1990
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 29 (17) , 4115-4120
- https://doi.org/10.1021/bi00469a014
Abstract
The mechanism of slow binding inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase by lovastatin, fluindostatin, and related compounds was studied. Several of these compounds, including lovastatin, were found to be slow binding, while other less potent inhibitors were not. From a comparison of kinetic parameters obtained by steady-state measurements and progress curve analysis, it was concluded that the slow binding inhibitors bind by a mechanism which is more accurately described by biphasic binding than by single-step binding. The overall association rates of the slow binding inhibitors range from 1 .times. 106 to 4 .times. 107 M-1 s-1, and the dissociation rates are in the range of 10-3 s-1. The structures of slow binding and reversible inhibitors were compared by using molecular modeling methods. From these comparisons, it was proposed that the slow binding and very potent inhibition of, for instance, lovastatin, is not simply a result of binding of a transition state or reaction intermediate analogue. The various lipophilic groups of the inhibitors that do not seem to be related to structural features of the substrate may also play a crucial role in determining the mechanism of binding of HMGR inhibitors.This publication has 15 references indexed in Scilit:
- CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal speciesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. Side-chain ester derivatives of mevinolinJournal of Medicinal Chemistry, 1986
- 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 2. Structural modification of 7-(substituted aryl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivativesJournal of Medicinal Chemistry, 1986
- 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 3. 7-(3,5-Disubstituted-[1,1'-biphenyl]-2-yl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivativesJournal of Medicinal Chemistry, 1986
- Mode of interaction of .beta.-hydroxy-.beta.-methylglutaryl coenzyme A reductase with strong binding inhibitors: compactin and related compoundsBiochemistry, 1985
- Crystallographic refinement and atomic models of two different forms of citrate synthase at 2·7 and 1·7 Å resolutionJournal of Molecular Biology, 1982
- Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.Proceedings of the National Academy of Sciences, 1980
- Improved methods for the solubilization and assay of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase.Journal of Lipid Research, 1979
- The protein data bank: A computer-based archival file for macromolecular structuresJournal of Molecular Biology, 1977
- The determination of enzyme inhibitor constantsBiochemical Journal, 1953